Patents by Inventor Sander J. Robins

Sander J. Robins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of vascular events using lipid-modifying compositions
    Publication number: 20020123524
    Abstract: The present invention pertains to methods for treating a patient who is at risk for a vascular (e.g., cardiovascular, cerebrovascular) event comprising administering to the patient an effective amount of a lipid-modifying drug. The present methods are particularly effective in patients having a lipid profile comprising a low Low Density Lipoprotein (LDL-C) and a low High Density Lipoprotein (HDL-C). Patients having low levels of LDL-C and HDL-C include diabetics. As a result, the present invention includes methods for treating diabetics by administering a lipid-modifying drug such as a fibric acid.
    Type: Application
    Filed: July 23, 2001
    Publication date: September 5, 2002
    Inventors: Sander J. Robins, Hanna Bloomfield Rubins, Dorothea Collins
  • Treatment of vascular events using lipid-modifying compositions
    Patent number: 6264960
    Abstract: The claimed invention pertains to methods for treating a patient who is at risk for a vascular (e.g., cardiovascular, cerebrovascular) event comprising administering to the patient an effective amount of a lipid-modifying drug. The claimed methods are particularly effective in patients having a lipid profile comprising a low Low Density Lipoprotein and a low High Density Lipoprotein.
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: July 24, 2001
    Inventors: Sander J. Robins, Hanna Bloomfield Rubins, Dorothea Collins
  • TREATMENT OF VASCULAR EVENTS USING LIPID-MODIFYING COMPOSITIONS
    Publication number: 20010008629
    Abstract: The claimed invention pertains to methods for treating a patient who is at risk for a vascular (e.g., cardiovascular, cerebrovascular) event comprising administering to the patient an effective amount of a lipid-modifying drug. The claimed methods are particularly effective in patients having a lipid profile comprising a low Low Density Lipoprotein and a low High Density Lipoprotein.
    Type: Application
    Filed: November 10, 1998
    Publication date: July 19, 2001
    Inventors: SANDER J. ROBINS, HANNA BLOOMFIELD RUBINS, DOROTHEA COLLINS